IN8bio, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 8.56 million compared to USD 7.53 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.3 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | 0.00% |
|
-31.97% | -27.54% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.54% | 44.12M | |
+14.84% | 121B | |
+18.31% | 112B | |
+4.45% | 22.57B | |
-18.26% | 20.82B | |
-16.80% | 16.19B | |
-42.36% | 16.17B | |
-14.23% | 16.3B | |
-0.68% | 13.17B | |
+21.87% | 11.11B |
- Stock Market
- Equities
- INAB Stock
- News IN8bio, Inc.
- IN8bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024